---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-005469"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T00:57:50.207492+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Avon Freight Group selects INBS fingerprint drug testing for 3 UK sites

## Summary
- Avon Freight Group selects INBS fingerprint drug testing for random testing across three UK sites.
- INBS now serves over 400 accounts in 19 countries; targeting U.S. expansion after FDA 510(k) submission in Dec 2024.
- UK drug testing market projected to reach $453M by 2030, positioning INBS for growth.
- Avon previously used external oral swab tests; switch aims for less invasive, cost-effective solution.

## SEC filing metadata
- accession: 0001493152-25-005469
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315225005469/0001493152-25-005469-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315225005469/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-005469
- JSON: https://secwatch.observer/filing/0001493152-25-005469.json
- Plain text: https://secwatch.observer/filing/0001493152-25-005469.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.